Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 19 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

47%

9 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

Phase 4

5(38.5%)

Phase 3

4(30.8%)

N/A

3(23.1%)

Phase 2

1(7.7%)

13Total

Phase 4(5)

Phase 3(4)

N/A(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials

NCT07507500Phase 4Not Yet Recruiting

Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months

Role: collaborator

NCT06686862Phase 3Recruiting

Non-Steroidal Anti-Inflammatory Drugs in Acute Myocarditis

Role: lead

NCT05223413Not ApplicableRecruiting

REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs

Role: lead

NCT03596385Phase 4Completed

TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"

Role: lead

NCT02596126Phase 3Completed

Secondary Prevention of Cardiovascular Disease in the Elderly Trial

Role: lead

NCT02693548Recruiting

The Spanish Familial Hypercholesterolaemia Cohort Study

Role: collaborator

NCT04696185Phase 4Completed

Dapagliflozin After Transcatheter Aortic Valve Implantation

Role: collaborator

NCT06102889Enrolling By Invitation

GUIDING MULTI-MODAL THERAPIES AGAINST MINIMAL RESIDUAL DISEASE BY LIQUID BIOPSIES

Role: collaborator

NCT03005366Phase 4Completed

Predictive Factors to Effectively Terminate Paroxysmal Atrial Fibrillation by Blocking Atrial Selective Ionic Currents

Role: collaborator

NCT05169320Unknown

Patient-TAILORed Ablation of Persistent AF Guided by Instantaneous Amplitude and Frequency Modulation Maps (TAILOR-AF)

Role: collaborator

NCT03248557Completed

Prognostic Value of Ventricular Fibrillation Spectral Analysis in Sudden Cardiac Death

Role: collaborator

NCT05184426Active Not Recruiting

MuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart Transplantation (LEONE-HT)

Role: collaborator

NCT01410318Active Not Recruiting

Progression of Early Subclinical Atherosclerosis

Role: lead

NCT02561065Not ApplicableCompleted

Long-term Impact Evaluation of a Worksite-based Lifestyle Intervention to Reduce Cardiovascular Risk in Office Workers

Role: lead

NCT01311700Phase 4Completed

Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The METOCARD-CNIC Trial.

Role: lead

NCT01579708Phase 3Completed

Evaluation of the Program SI! for Preschool Education: A School-Based Randomized Controlled Trial

Role: lead

NCT02775539Phase 2Unknown

Beta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure

Role: lead

NCT01321255Phase 3Completed

Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.

Role: lead

NCT00674401Not ApplicableCompleted

Radiofrequency Ablation of Drivers of Atrial Fibrillation

Role: collaborator

All 19 trials loaded